Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginkgolone ester is a standardized pharmaceutical extract derived from the leaves of *Ginkgo biloba*, primarily composed of ginkgo flavone glycosides and terpene lactones. Developed and extensively researched by institutions such as Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine, it is utilized for its neuroprotective, cardiovascular, and potential anti-tumor properties. The extract functions primarily by antagonizing platelet-activating factor (PAF) receptors and acting as a potent free radical scavenger, which collectively improve microcirculation and mitigate oxidative stress. In the context of cognitive impairment and vascular dementia, ginkgolone ester is used to enhance cerebral blood flow and protect neuronal integrity. In oncology, specifically breast cancer, it is being investigated for its ability to inhibit tumor cell proliferation and induce apoptosis, often serving as an adjuvant therapy to enhance the efficacy of chemotherapy or reduce its associated toxicities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginkgolone ester.